Transcript segment

Baric Transcribed Interview (Redacted), p.22 · baric_ti:utt:00117

Date: 2026-04-10 09:00 (day precision)
Type: transcript segment · interview
recipient: Christina Salazar, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker: Ralph S. Baric
Topics: Proximal Origin paper

I got to meet him around 2004. I can't tell you exactly when. I mean, scientific meetings, you run into people all the time. But I would guess it would start around 2014 we ran into a meeting, I think at the NEIDL together, and had some discussions. And I visited his place afterwards. We had common interests, but we didn't effectively start working together until later in 2014, on some of the work on the 2015 paper, that was published in Nature Medicine.

Extracted statements

Rule-extracted, not adjudicated. The grade says what may be done with each one; read the document above before relying on any of them.

Statement	Grade	Attribution	Stance
We had common interests, but we didn't effectively start working together until later in 2014, on some of the work on the 2015 paper, that was published in Nature Medicine.	own voice, substantive	speaker_own	asserts

Statement

Grade

Attribution

Stance

We had common interests, but we didn't effectively start working together until later in 2014, on some of the work on the 2015 paper, that was published in Nature Medicine.

own voice, substantive

speaker_own

asserts

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

2026-04-10 09:00 Ralph S. Baric open

I told you that. I think it was around the 4th, that told me it was a coronavirus related to SARS, that was 78 percent identical.
2026-04-10 09:00 Christina Salazar open

Okay.
2026-04-10 09:00 Ralph S. Baric open

That means basically it has 6,000 nucleotides. So if you think about a tree, SARS coronavirus is on one branch of that tree, and SARS-2 is on a totally different branch of that tree.
2026-04-10 09:00 Christina Salazar open

Okay. And so your conversations with DC.Scheduling@LexitasLegal.com Peter Daszak during that time, when did you start working with Peter Daszak? You had a relationship with him.
2026-04-10 09:00 Ralph S. Baric

I got to meet him around 2004. I can't tell you exactly when. I mean, scientific meetings, you run into people all the time. But I would guess it would start around 2014 we ran into a meeting, I think at the NEIDL together, and had some discussions. And I visited his place afterwards. We had common interests, but we didn't effectively start working together until later in 2014, on some of the work on the 2015 paper, that was published in Nature Medicine.
2026-04-10 09:00 Christina Salazar open

Okay. Why don't we skip to that.
2026-04-10 09:00 Ralph S. Baric open

I mean, from my perspective, and just looking at it from a scientific perspective, he made major contributions into identifying emerging infectious disease hotspots around the world. He worked extensively with China on SARS coronavirus in 2003. He's sort of a microbial ecologist, very different field than I do. But we would have mutual interests to talk about emerging viruses.
2026-04-10 09:00 Christina Salazar open

And did he have people on the ground over in Wuhan in early 2020?
2026-04-10 09:00 Ralph S. Baric open

So I was not part of his RO1 grant that went from like 2014 to 2019. So on that grant, as you know, part of that money went to the Wuhan Institute of DC.Scheduling@LexitasLegal.com Virology. So I guess you could say he had a collaborative group in China, and I would imagine that he had people moving back and forth between the two, the U.S. and China.

Full conversation →